Recently Viewed
empty-cart

There are no Recent Items

Close
Login/Register

Close
Single User License Price USD 250
Single User License Price INR 17198
Corporate User License Price USD 750
Corporate User License Price INR 51593
Site License Price USD 500
Site License Price INR 34395
Request a Quote

Report Title

Emergent BioSolutions Inc (EBS) - Medical Equipment - Deals and Alliances Profile

Quote Request for License Type
License Type Price  
Single User License USD 250
Site License USD 500
Enterprise Wide License USD 750
"Thanks for submitting the form. Our marketing team will connect back to you for the budget constraint."
Close
REQUEST A CUSTOMIZED RESEARCH

Report Title

Emergent BioSolutions Inc (EBS) - Medical Equipment - Deals and Alliances Profile


Quote Request for License Type
License Type Price  
Single User License USD 250
"Thanks for letting us know your requirement. Our research team will connect back to you for the bespoke requirement."
Close
REQUEST FOR SAMPLE REPORT

Report Title

Emergent BioSolutions Inc (EBS) - Medical Equipment - Deals and Alliances Profile

"Thanks for submitting the form. The concerned team will send the sample report in the next 12 hours."
"Thank you for downloading the sample report."
Close

Emergent BioSolutions Inc (EBS) - Medical Equipment - Deals and Alliances Profile



Executive Summary

Summary

Emergent BioSolutions Inc (Emergent) is a life sciences company. It focuses on protecting and enhancing life by providing specialized products to governments and healthcare providers. The company develops specialty products targeting public health threats and emerging infectious diseases. It's product portfolio includes vaccines and antibody therapeutics with focus on infectious diseases, autoimmune diseases and cancer. It uses multiple platform technologies, including the MVAtor and Emergard for delivery of its products. Its marketed products include BioThrax (anthrax vaccine adsorbed); WinRho SDF (Rho(D) immune globulin intravenous; (RSDL) reactive skin decontamination lotion; and HepaGam B for the treatment of hepatitis B. Emergent also has a developmental pipeline of candidates targeting dengue and other influenza infections. The company distributes its products in the US and Canada through its commercial sales forces and third party distributors. Emergent is headquartered in Rockville, Maryland, the US.

Emergent BioSolutions Inc (EBS)-Medical Equipment-Deals and Alliances Profile provides you comprehensive data and trend analysis of the company's Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Medical eTrack deals database, and primary and secondary research.

Scope

- Financial Deals-Analysis of the company's financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.

- Deals by Year-Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.

- Deals by Type-Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.

- Deals by Region-Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.

- Deals by Sub-sector-Chart and table showing information on the number of deals and value reported by the company, by sub-sector.

- Major Deals-Information on the company's major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company's (major public companies) key financial metrics and ratios.

- Business Description-A brief description of the company's operations.

- Key Employees-A list of the key executives of the company.

- Important Locations and Subsidiaries-A list and contact details of key centers of operation and subsidiaries of the company.

- Key Competitors-A list of the key competitors of the company.

- Key Recent Developments-A brief on recent news about the company.

Reasons to buy

Get detailed information on the company's financial deals that enable you to understand the company's expansion/divestiture and fund requirements

- The profile enables you to analyze the company's financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company's business segments' expansion / divestiture strategy

- The profile presents deals from the company's core business segments' perspective to help you understand its corporate strategy.

Access elaborate information on the company's recent financial deals that enable you to understand the key deals which have shaped the company

- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company's key financial metrics and ratios.

Equip yourself with detailed information about the company's operations to identify potential customers and suppliers.

- The profile analyzes the company's business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company

- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research

- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

Table of Contents

Table of Contents 3

List of Tables 5

List of Figures 5

Emergent BioSolutions Inc, Medical Equipment, Deals By Year, 2012 to YTD 2018 6

Emergent BioSolutions Inc, Medical Equipment Deals By Type, 2012 to YTD 2018 7

Emergent BioSolutions Inc, Medical Equipment, Deals By Region, 2012 to YTD 2018 8

Emergent BioSolutions Inc, Medical Equipment, Deals By Market, 2012 to YTD 2018 9

Emergent BioSolutions Inc, Medical Equipment, Deals Summary, 2012 to YTD 2018 10

Emergent BioSolutions Inc, Medical Equipment, Deal Details 11

Partnerships 11

Emergent BioSolutions Enters into Licensing Agreement with Pharma Consult 11

Debt Offering 12

Emergent BioSolutions Completes Private Placement Of Notes Due 2021 For USD 250 Million 12

Acquisition 14

Emergent BioSolutions Acquires Unither Virology from United Therapeutics 14

Emergent BioSolutions Inc-Key Competitors 15

Emergent BioSolutions Inc-Key Employees 16

Emergent BioSolutions Inc-Locations And Subsidiaries 17

Head Office 17

Other Locations & Subsidiaries 17

Joint Venture 19

Recent Developments 20

Strategy And Business Planning 20

Sep 24, 2018: Emergent BioSolutions expands manufacturing capability with ABEC dual purpose single-use microbial fermentation / mammalian cell culture systems 20

Jun 07, 2018: Emergent BioSolutions Announces USD 50 Million Expansion of Baltimore Fill/Finish Facility 21

May 10, 2017: Emergent BioSolutions Unveils Its Expanded Center for Innovation in Advanced Development and Manufacturing in Baltimore 22

Financial Announcements 24

Aug 02, 2018: Emergent BioSolutions reports financial results for second quarter and six months of 2018 24

May 03, 2018: Emergent BioSolutions Reports First Quarter 2018 Financial Results 27

Feb 22, 2018: Emergent BioSolutions Reports Fourth Quarter and Twelve Months 2017 Financial Results 30

Jan 08, 2018: Emergent BioSolutions Announces Preliminary 2017 Financial Results and Provides 2018 Financial Outlook 33

Nov 02, 2017: Emergent BioSolutions Reports Third Quarter and Nine Months 2017 Financial Results; Raises Calendar Year 2017 Guidance 34

Aug 03, 2017: Emergent BioSolutions Reports Second Quarter and Six Months 2017 Financial Results; Reaffirms Calendar Year 2017 Guidance 37

May 04, 2017: Emergent BioSolutions Reports First Quarter 2017 Financial Results; Reaffirms 2017 Guidance 40

Feb 23, 2017: Emergent BioSolutions Reports Fourth Quarter and Twelve Months 2016 Financial Results; Reaffirms 2017 Guidance and Provides 2020 Goals 42

Jan 09, 2017: Emergent BioSolutions Announces Preliminary 2016 Financial Results and Provides 2017 Financial Outlook 45

Corporate Communications 46

Mar 26, 2018: Emergent BioSolutions Announces Executive Management Changes That Enhance Execution of Company's Growth Strategy 46

Oct 02, 2017: Emergent BioSolutions Announces Closing of New USD 200 Million Senior Secured Credit Facility 47

Other Significant Developments 48

Jul 31, 2017: Emergent BioSolutions Awarded USD 23 Million to Develop Novel Multi-Drug Auto-Injector for U.S. Department of Defense 48

Appendix 49

Methodology 49

About GlobalData 49

Contact Us 49

Disclaimer 49

To know more information on Purchase by Section, please send a mail to sales@kenresearch.com

List of Figures

Emergent BioSolutions Inc, Medical Equipment, Deals by Type, 2012 to YTD 2018 2

Emergent BioSolutions Inc, Medical Equipment, Deals By Year, 2012 to YTD 2018 2

Emergent BioSolutions Inc, Medical Equipment, Deals By Region, 2012 to YTD 2018 2

Emergent BioSolutions Inc, Medical Equipment, Deals By Market, 2012 to YTD 2018 2

Emergent BioSolutions Inc, Medical Equipment, Deals By Year, 2012 to YTD 2018 6

Emergent BioSolutions Inc, Medical Equipment, Deals by Type, 2012 to YTD 2018 7

Emergent BioSolutions Inc, Medical Equipment, Deals By Region, 2012 to YTD 2018 8

Emergent BioSolutions Inc, Medical Equipment, Deals by Market, 2012 to YTD 2018 9

List of Tables

Emergent BioSolutions Inc, Medical Equipment, Key Facts, 2017 2

Emergent BioSolutions Inc, Medical Equipment, Deals Summary, 2012 to YTD 2018 2

Emergent BioSolutions Inc, Medical Equipment, Deals By Year, 2012 to YTD 2018 6

Emergent BioSolutions Inc, Medical Equipment Deals By Type, 2012 to YTD 2018 7

Emergent BioSolutions Inc, Medical Equipment, Deals By Region, 2012 to YTD 2018 8

Emergent BioSolutions Inc, Deals By Market, 2012 to YTD 2018 9

Emergent BioSolutions Inc, Medical Equipment, Deals Summary, 2012 to YTD 2018 10

Emergent BioSolutions Enters into Licensing Agreement with Pharma Consult 11

Emergent BioSolutions Completes Private Placement Of Notes Due 2021 For USD 250 Million 12

Emergent BioSolutions Acquires Unither Virology from United Therapeutics 14

Emergent BioSolutions Inc, Key Competitors 15

Emergent BioSolutions Inc, Key Employees 16

Emergent BioSolutions Inc, Other Locations 17

Emergent BioSolutions Inc, Subsidiaries 17

Emergent BioSolutions Inc, Joint Venture 19

Single User License:
Report can be used by individual purchaser only

Site License:
Report can be shared by unlimited users within one corporate location, e.g. a regional office

Corporate User License:
Report can be shared globally by unlimited users within the purchasing corporation e.g. all employees of a single company

Emergent BioSolutions Inc, Deal Analysis, Mergers, Acquisitions, Asset Purchases, Asset Divestitures, Company Divestitures, Equity Offerings, Capital Raising, Debt Offerings, IPOs, Initial Public Offering, Private Placement, Private Investment In Public Equities, Secondary Offerings, Follow-On Offerings, Debt Private Placement, Public Debt Placement, Partnerships, Joint Venture, Licensing Agreements, Co-Marketing Agreements, Upfront Payment, Milestone Payment, Phases, Clinical Trials, Private Equity, Venture Capital, PE,VC, Asset Finance, Project Finance, Tax Equity Financing, Bond Financing, Lease Financing, New Build Financing, Deal Analysis By Market/sector, Deal Analysis By Geography, Deal Analysis By Deal Types, Key Employees, Locations And Subsidiaries, Competitors, Recent News, Company Overview, Key Facts, Deals By Year, Deal Details, Recent Developments, Significant Developments.


Related Products in vertical
red-whiteline

RECENT VIEWED REPORTS



Sign up for newsletter

Close
Apply For Job

  • Applicant Name
  • Job Function
  • Total Experience
  • Skills
  • Email ID
  • Notice Period
  • Current CTC & Expected CTC
  • Phone Number
  • Validation
  • captcha  info-icon

    If validation code does not match, please refresh the page.

  • "Your resume has been successfully received. HR will connect you within 14 days in case your resume gets shortlisted."
Close
Download Company Brochure

  • Name
  • Email
  • Company Name
  • Select Country*
  • Phone Number
  • Validation
  •   info-icon

    If validation code does not match, please refresh the page.

Close
Engage With Us

  • Name
  • Designation
  • Email
  • Phone No.
  • Company Name
  • Company URL
  • Select Country*
  • Requirements/ Comments
  • Validation
  • captcha  info-icon

    If validation code does not match, please refresh the page.

  • "Thanks for submitting the form. The concerned team will respond to your query in the next 8-12 hours"
Close

Compare

Expand

person